2 Top Healthcare Stocks to Buy in February

After underperforming broader equities implicit the past fewer years, volition the healthcare assemblage yet rebound and present above-average returns from present connected out? That's hard to say. Whatever the case, determination are plentifulness of charismatic healthcare stocks investors should see buying and holding connected to done the adjacent 5 years and beyond.

Here are 2 candidates: Intuitive Surgical (NASDAQ: ISRG) and Vertex Pharmaceuticals (NASDAQ: VRTX).

Will AI make the world's archetypal trillionaire? Our squad conscionable released a study connected the 1 little-known company, called an "Indispensable Monopoly" providing the captious exertion Nvidia and Intel some need. Continue »

Intuitive Surgical faced challenges past year. High tariffs impacted its fiscal results, portion it is seeing accrued contention successful the robotic-assisted country (RAS) market, a niche wherever it is simply a leader. Further, the company's guidance for the fiscal twelvemonth 2026 wasn't arsenic beardown arsenic the marketplace wanted. However, adjacent with imaginable near-term volatility, Intuitive Surgical's semipermanent outlook is strong. It operates successful an underpenetrated RAS marketplace and develops immoderate of the starring robot country devices, including its celebrated da Vinci system, which helps surgeons execute minimally invasive procedures.

Intuitive Surgical besides benefits from a beardown competitory vantage owed to switching costs, arsenic its devices are costly capable that infirmary systems won't privation to regenerate them. It ended the 4th fourth with an installed basal of 11,106, up 12% from the year-ago period. And arsenic this fig increases, truthful volition process volume, an important maturation operator for the aesculapian instrumentality specialist. Intuitive Surgical's moat tin assistance it enactment up of the contention portion besides giving it flexibility to woody with tariffs, for instance, by leveraging its beardown pricing power.

So, adjacent with the challenges it faces, Intuitive Surgical's banal is simply a apical prime this period for buy-and-hold investors fixed its semipermanent prospects, contempt its 13% diminution implicit the trailing-12-month period.

Vertex Pharmaceuticals has respective catalysts connected the skyline that could boost its stock terms and assistance it physique a beardown instauration for the future. Although the biotech has been hugely palmy successful its halfway therapeutic country -- Vertex Pharmaceuticals markets the lone drugs successful the satellite that dainty the underlying causes of cystic fibrosis (CF) -- the institution is present expanding into caller territories. Vertex plans connected submitting regulatory applications for zimislecel, an investigational therapy for benignant 1 diabetes, this year.